GUIDANT VASCULAR INTERVENTION
Manufacturer adverse-event records for GUIDANT VASCULAR INTERVENTION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1996–2007 · thin-book · elevated Death-code · injury-heavy
Volume signature
GUIDANT VASCULAR INTERVENTION is a thinner MAUDE footprint
GUIDANT VASCULAR INTERVENTION accounts for 4,011 FDA MAUDE reports (#417 of 434, thin-book tercile). Death-coded event_type share is 4.31% (elevated); Injury share 63.6% (injury-heavy).
What the volume reading shows for GUIDANT VASCULAR INTERVENTION
The standout signal for GUIDANT VASCULAR INTERVENTION is filing volume: 4,011 adverse-event reports in FDA MAUDE (#417 of 434, thin-book). Death-coded event_type share sits at 4.31% (elevated).
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 20 device types, led in this extract by Injury at 2,552 (63.6% of event_type total). Peak single-year volume reaches 666 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.